{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T22:53:36Z","timestamp":1762642416516,"version":"3.37.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T00:00:00Z","timestamp":1602892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T00:00:00Z","timestamp":1602892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81701316"],"award-info":[{"award-number":["81701316"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangsu Province Health Research Project","award":["YG201307"],"award-info":[{"award-number":["YG201307"]}]},{"name":"Suzhou Science and Technology Plan","award":["sys2018025","SYS2019025"],"award-info":[{"award-number":["sys2018025","SYS2019025"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s11010-020-03931-3","type":"journal-article","created":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T18:02:33Z","timestamp":1602957753000},"page":"619-631","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Engrafted primary type-2 astrocytes improve the recovery of the nigrostriatal pathway in a rat model of Parkinson's disease"],"prefix":"10.1007","volume":"476","author":[{"given":"Yanyun","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-jun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinghui","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiabing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingxia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1124-8979","authenticated-orcid":false,"given":"Chun-lin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,17]]},"reference":[{"key":"3931_CR1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.lfs.2019.03.057","volume":"226","author":"C Raza","year":"2019","unstructured":"Raza C, Anjum R, Shakeel NUA (2019) Parkinson\u2019s disease: mechanisms, translational models and management strategies. Life Sci 226:77\u201390. https:\/\/doi.org\/10.1016\/j.lfs.2019.03.057","journal-title":"Life Sci"},{"key":"3931_CR2","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","volume":"68","author":"ER Dorsey","year":"2007","unstructured":"Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, Marshall FJ, Ravina BM, Schifitto G, Siderowf A, Tanner CM (2007) Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 68:384\u2013386. https:\/\/doi.org\/10.1212\/01.wnl.0000247740.47667.03","journal-title":"Neurology"},{"key":"3931_CR3","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","volume":"95","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M (1998) alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with lewy bodies. Proc Natl Acad Sci USA 95:6469\u20136473. https:\/\/doi.org\/10.1073\/pnas.95.11.6469","journal-title":"Proc Natl Acad Sci USA"},{"key":"3931_CR4","doi-asserted-by":"publisher","first-page":"438","DOI":"10.23736\/S0026-4806.17.05246-6","volume":"108","author":"S Bandres-Ciga","year":"2017","unstructured":"Bandres-Ciga S, Ruz C, Barrero FJ, Escamilla-Sevilla F, Pelegrina J, Vives F, Duran R (2017) Structural genomic variations and Parkinson\u2019s disease. Minerva Med 108:438\u2013447. https:\/\/doi.org\/10.23736\/S0026-4806.17.05246-6","journal-title":"Minerva Med"},{"key":"3931_CR5","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3390\/ph5060553","volume":"5","author":"MS Fiandaca","year":"2012","unstructured":"Fiandaca MS, Bankiewicz KS, Federoff HJ (2012) Gene therapy for the treatment of Parkinson\u2019s disease: the nature of the biologics expands the future indications. Pharmaceuticals 5:553\u2013590. https:\/\/doi.org\/10.3390\/ph5060553","journal-title":"Pharmaceuticals"},{"key":"3931_CR6","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1136\/jnnp-2014-308119","volume":"86","author":"JC Rothlind","year":"2015","unstructured":"Rothlind JC, York MK, Carlson K, Luo P, Marks WJ Jr, Weaver FM, Stern M, Follett K, Reda D, Group CSPS (2015) Neuropsychological changes following deep brain stimulation surgery for Parkinson\u2019s disease: comparisons of treatment at pallidal and subthalamic targets versus best medical therapy. J Neurol Neurosurg Psychiatry 86:622\u2013629. https:\/\/doi.org\/10.1136\/jnnp-2014-308119","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3931_CR7","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41582-019-0155-7","volume":"15","author":"A Elkouzi","year":"2019","unstructured":"Elkouzi A, Vedam-Mai V, Eisinger RS, Okun MS (2019) Emerging therapies in Parkinson disease\u2014repurposed drugs and new approaches. Nat Rev Neurol 15:204\u2013223. https:\/\/doi.org\/10.1038\/s41582-019-0155-7","journal-title":"Nat Rev Neurol"},{"key":"3931_CR8","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1007\/s00415-018-8945-1","volume":"265","author":"S Picazio","year":"2018","unstructured":"Picazio S, Ponzo V, Caltagirone C, Brusa L, Koch G (2018) Dysfunctional inhibitory control in Parkinson\u2019s disease patients with levodopa-induced dyskinesias. J Neurol 265:2088\u20132096. https:\/\/doi.org\/10.1007\/s00415-018-8945-1","journal-title":"J Neurol"},{"key":"3931_CR9","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1007\/s00702-013-0981-5","volume":"120","author":"KR Chaudhuri","year":"2013","unstructured":"Chaudhuri KR, Rizos A, Sethi KD (2013) Motor and nonmotor complications in Parkinson\u2019s disease: an argument for continuous drug delivery? J Neural Transm 120:1305\u20131320. https:\/\/doi.org\/10.1007\/s00702-013-0981-5","journal-title":"J Neural Transm"},{"key":"3931_CR10","doi-asserted-by":"publisher","first-page":"12842","DOI":"10.1523\/JNEUROSCI.4156-09.2009","volume":"29","author":"AC Vernon","year":"2009","unstructured":"Vernon AC (2009) Mice with reduced vesicular monoamine storage content display nonmotor features of Parkinson\u2019s disease. J Neurosci 29:12842\u201312844. https:\/\/doi.org\/10.1523\/JNEUROSCI.4156-09.2009","journal-title":"J Neurosci"},{"key":"3931_CR11","doi-asserted-by":"publisher","first-page":"e40166","DOI":"10.1371\/journal.pone.0040166","volume":"7","author":"IM Lelieveld","year":"2012","unstructured":"Lelieveld IM, Muller ML, Bohnen NI, Koeppe RA, Chervin RD, Frey KA, Albin RL (2012) The role of serotonin in sleep disordered breathing associated with Parkinson disease: a correlative [11C]DASB PET imaging study. PLoS ONE 7:e40166. https:\/\/doi.org\/10.1371\/journal.pone.0040166","journal-title":"PLoS ONE"},{"key":"3931_CR12","first-page":"182","volume":"33","author":"X Lu","year":"2015","unstructured":"Lu X, Fu X, Zhai W, Xia C (2015) Behavioral evaluation and changes in levels of monoamine neurotransmitter within the nigrostriatal pathway in rat models of Parkinson\u2019s disease. Chin J Clinicalanatomy 33:182\u2013188","journal-title":"Chin J Clinicalanatomy"},{"key":"3931_CR13","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1083\/jcb.144.3.403","volume":"144","author":"S Kuroda","year":"1999","unstructured":"Kuroda S, Nakagawa N, Tokunaga C, Tatematsu K, Tanizawa K (1999) Mammalian homologue of the Caenorhabditis elegans UNC-76 protein involved in axonal outgrowth is a protein kinase C zeta-interacting protein. J Cell Biol 144:403\u2013411","journal-title":"J Cell Biol"},{"key":"3931_CR14","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.bbrc.2006.11.142","volume":"353","author":"J Ikuta","year":"2007","unstructured":"Ikuta J, Maturana A, Fujita T, Okajima T, Tatematsu K, Tanizawa K, Kuroda S (2007) Fasciculation and elongation protein zeta-1 (FEZ1) participates in the polarization of hippocampal neuron by controlling the mitochondrial motility. Biochem Biophys Res Commun 353:127\u2013132. https:\/\/doi.org\/10.1016\/j.bbrc.2006.11.142","journal-title":"Biochem Biophys Res Commun"},{"key":"3931_CR15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.molbrainres.2003.11.020","volume":"122","author":"A Honda","year":"2004","unstructured":"Honda A, Miyoshi K, Baba K, Taniguchi M, Koyama Y, Kuroda S, Katayama T, Tohyama M (2004) Expression of fasciculation and elongation protein zeta-1 (FEZ1) in the developing rat brain. Brain Res Mol Brain Res 122:89\u201392. https:\/\/doi.org\/10.1016\/j.molbrainres.2003.11.020","journal-title":"Brain Res Mol Brain Res"},{"key":"3931_CR16","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s11010-009-0030-8","volume":"325","author":"J He","year":"2009","unstructured":"He J, Liu J, Zhang Z, Sun M, Zhu T, Xia C (2009) Expression of fasciculation and elongation protein zeta-1 (FEZ1) in cultured rat neonatal astrocytes. Mol Cell Biochem 325:159\u2013167. https:\/\/doi.org\/10.1007\/s11010-009-0030-8","journal-title":"Mol Cell Biochem"},{"key":"3931_CR17","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1073\/pnas.0600337103","volume":"103","author":"JY Jeong","year":"2006","unstructured":"Jeong JY, Einhorn Z, Mercurio S, Lee S, Lau B, Mione M, Wilson SW, Guo S (2006) Neurogenin1 is a determinant of zebrafish basal forebrain dopaminergic neurons and is regulated by the conserved zinc finger protein Tof\/Jezl. Proc Natl Acad Sci USA 103:5143\u20135148. https:\/\/doi.org\/10.1073\/pnas.0600337103","journal-title":"Proc Natl Acad Sci USA"},{"key":"3931_CR18","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1093\/hmg\/ddn215","volume":"17","author":"N Sakae","year":"2008","unstructured":"Sakae N, Yamasaki N, Kitaichi K, Fukuda T, Yamada M, Yoshikawa H, Hiranita T, Tatsumi Y, Kira J, Yamamoto T, Miyakawa T, Nakayama KI (2008) Mice lacking the schizophrenia-associated protein FEZ1 manifest hyperactivity and enhanced responsiveness to psychostimulants. Hum Mol Genet 17:3191\u20133203. https:\/\/doi.org\/10.1093\/hmg\/ddn215","journal-title":"Hum Mol Genet"},{"key":"3931_CR19","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/nan.12077","volume":"40","author":"YY Sun","year":"2014","unstructured":"Sun YY, Zhang Y, Sun XP, Liu TY, Liu ZH, Chen G, Xia CL (2014) Fasciculation and elongation protein zeta-1 (FEZ1) expression in reactive astrocytes in a rat model of Parkinson\u2019s disease. Neuropathol Appl Neurobiol 40:164\u2013176. https:\/\/doi.org\/10.1111\/nan.12077","journal-title":"Neuropathol Appl Neurobiol"},{"key":"3931_CR20","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1385\/MN:25:3:245","volume":"25","author":"MA Mena","year":"2002","unstructured":"Mena MA, de Bernardo S, Casarejos MJ, Canals S, Rodriguez-Martin E (2002) The role of astroglia on the survival of dopamine neurons. Mol Neurobiol 25:245\u2013263. https:\/\/doi.org\/10.1385\/MN:25:3:245","journal-title":"Mol Neurobiol"},{"key":"3931_CR21","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.expneurol.2004.07.004","volume":"190","author":"AG Dervan","year":"2004","unstructured":"Dervan AG, Meshul CK, Beales M, McBean GJ, Moore C, Totterdell S, Snyder AK, Meredith GE (2004) Astroglial plasticity and glutamate function in a chronic mouse model of Parkinson\u2019s disease. Exp Neurol 190:145\u2013156. https:\/\/doi.org\/10.1016\/j.expneurol.2004.07.004","journal-title":"Exp Neurol"},{"key":"3931_CR22","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/303390a0","volume":"303","author":"MCMR Raff","year":"1983","unstructured":"Raff MCMR, Noble M (1983) A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature 303:390\u2013396","journal-title":"Nature"},{"key":"3931_CR23","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/323335a0","volume":"323","author":"C Ffrench-Constant","year":"1986","unstructured":"Ffrench-Constant C, Raff MC (1986) The oligodendrocyte-type-2 astrocyte cell lineage is specialized for myelination. Nature 323:335\u2013338. https:\/\/doi.org\/10.1038\/323335a0","journal-title":"Nature"},{"key":"3931_CR24","first-page":"153","volume":"38","author":"L Chunpeng","year":"2007","unstructured":"Chunpeng L, Ye Z, Chun-Lin X, Hui S, Jing Z, Zhifang L (2007) The expression of nestin and SSEA-1 in the rat type-2 astrocytes. Acta Anat Sin 38:153\u2013157","journal-title":"Acta Anat Sin"},{"key":"3931_CR25","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1126\/science.289.5485.1754","volume":"289","author":"T Kondo","year":"2000","unstructured":"Kondo T, Raff M (2000) Oligodendrocyte precursor cells reprogrammed to become multipotential CNS stem cells. Science 289:1754\u20131757","journal-title":"Science"},{"key":"3931_CR26","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1101\/gad.309404","volume":"18","author":"T Kondo","year":"2004","unstructured":"Kondo T, Raff M (2004) Chromatin remodeling and histone modification in the conversion of oligodendrocyte precursors to neural stem cells. Genes Dev 18:2963\u20132972. https:\/\/doi.org\/10.1101\/gad.309404","journal-title":"Genes Dev"},{"key":"3931_CR27","volume-title":"The rat brain in stereotaxic coordinates","author":"GWC Paxinos","year":"2007","unstructured":"Paxinos GWC (2007) The rat brain in stereotaxic coordinates, 6th edn. Academic Press, San Diego","edition":"6"},{"key":"3931_CR28","doi-asserted-by":"publisher","first-page":"3548","DOI":"10.1039\/b716979e","volume":"10","author":"RR Gullapalli","year":"2008","unstructured":"Gullapalli RR, Demirel MC, Butler PJ (2008) Molecular dynamics simulations of DiI-C18(3) in a DPPC lipid bilayer. Phys Chem Chem Phys 10:3548\u20133560. https:\/\/doi.org\/10.1039\/b716979e","journal-title":"Phys Chem Chem Phys"},{"key":"3931_CR29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jneumeth.2008.07.003","volume":"174","author":"Y Matsubayashi","year":"2008","unstructured":"Matsubayashi Y, Iwai L, Kawasaki H (2008) Fluorescent double-labeling with carbocyanine neuronal tracing and immunohistochemistry using a cholesterol-specific detergent digitonin. J Neurosci Methods 174:71\u201381. https:\/\/doi.org\/10.1016\/j.jneumeth.2008.07.003","journal-title":"J Neurosci Methods"},{"key":"3931_CR30","doi-asserted-by":"publisher","first-page":"4656539","DOI":"10.1155\/2016\/4656539","volume":"2016","author":"X Chen","year":"2016","unstructured":"Chen X, Lu M, Ma N, Yin G, Cui C, Zhao S (2016) Dynamic tracking of injected mesenchymal stem cells after myocardial infarction in rats: a serial 7T MRI study. Stem Cells Int 2016:4656539. https:\/\/doi.org\/10.1155\/2016\/4656539","journal-title":"Stem Cells Int"},{"key":"3931_CR31","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ntt.2013.06.002","volume":"39","author":"Z Lin","year":"2013","unstructured":"Lin Z, Dodd CA, Filipov NM (2013) Short-term atrazine exposure causes behavioral deficits and disrupts monoaminergic systems in male C57BL\/6 mice. Neurotoxicol Teratol 39:26\u201335. https:\/\/doi.org\/10.1016\/j.ntt.2013.06.002","journal-title":"Neurotoxicol Teratol"},{"key":"3931_CR32","doi-asserted-by":"publisher","first-page":"9450137","DOI":"10.1155\/2016\/9450137","volume":"2016","author":"W Zhang","year":"2016","unstructured":"Zhang W, He H, Song H, Zhao J, Li T, Wu L, Zhang X, Chen J (2016) Neuroprotective effects of salidroside in the MPTP mouse model of Parkinson\u2019s disease: involvement of the PI3K\/Akt\/GSK3beta pathway. Parkinsons Dis 2016:9450137. https:\/\/doi.org\/10.1155\/2016\/9450137","journal-title":"Parkinsons Dis"},{"key":"3931_CR33","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2174\/187152710791292639","volume":"9","author":"F Le","year":"2010","unstructured":"Le F, Tirolo C, Testa N, Caniglia S, Morale MC, Marchetti B (2010) Glia as a turning point in the therapeutic strategy of Parkinson\u2019s disease. CNS Neurol Disord Drug Targets 9:349\u2013372","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"3931_CR34","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.brainresrev.2006.12.001","volume":"54","author":"C Grothe","year":"2007","unstructured":"Grothe C, Timmer M (2007) The physiological and pharmacological role of basic fibroblast growth factor in the dopaminergic nigrostriatal system. Brain Res Rev 54:80\u201391. https:\/\/doi.org\/10.1016\/j.brainresrev.2006.12.001","journal-title":"Brain Res Rev"},{"key":"3931_CR35","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1126\/science.8493557","volume":"260","author":"LF Lin","year":"1993","unstructured":"Lin LF, Doherty DH, Lile JD, Bektesh S, Collins F (1993) GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260:1130\u20131132","journal-title":"Science"},{"key":"3931_CR36","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.nbd.2006.04.008","volume":"23","author":"A Saavedra","year":"2006","unstructured":"Saavedra A, Baltazar G, Santos P, Carvalho CM, Duarte EP (2006) Selective injury to dopaminergic neurons up-regulates GDNF in substantia nigra postnatal cell cultures: role of neuron-glia crosstalk. Neurobiol Dis 23:533\u2013542. https:\/\/doi.org\/10.1016\/j.nbd.2006.04.008","journal-title":"Neurobiol Dis"},{"key":"3931_CR37","first-page":"168","volume":"146","author":"PS Petrova","year":"2004","unstructured":"Petrova PS, Raibekas A, Pevsner J, Vigo N, Anafi M, Moore MK, Peaire A, Shridhar V, Smith DI, Kelly J, Durocher Y, Commissiong JW (2004) Discovering novel phenotype-selective neurotrophic factors to treat neurodegenerative diseases. Prog Brain Res 146:168\u2013183","journal-title":"Prog Brain Res"},{"key":"3931_CR38","doi-asserted-by":"publisher","first-page":"7153","DOI":"10.1523\/JNEUROSCI.21-18-07153.2001","volume":"21","author":"B Seri","year":"2001","unstructured":"Seri B, Garcia-Verdugo JM, McEwen BS, Alvarez-Buylla A (2001) Astrocytes give rise to new neurons in the adult mammalian hippocampus. J Neurosci 21:7153\u20137160","journal-title":"J Neurosci"},{"key":"3931_CR39","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1083\/jcb.103.1.171","volume":"103","author":"MG Honig","year":"1986","unstructured":"Honig MG, Hume RI (1986) Fluorescent carbocyanine dyes allow living neurons of identified origin to be studied in long-term cultures. J Cell Biol 103:171\u2013187","journal-title":"J Cell Biol"},{"key":"3931_CR40","doi-asserted-by":"publisher","first-page":"4148","DOI":"10.1073\/pnas.071540198","volume":"98","author":"G Sharma","year":"2001","unstructured":"Sharma G, Vijayaraghavan S (2001) Nicotinic cholinergic signaling in hippocampal astrocytes involves calcium-induced calcium release from intracellular stores. Proc Natl Acad Sci USA 98:4148\u20134153. https:\/\/doi.org\/10.1073\/pnas.071540198","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-020-03931-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-020-03931-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-020-03931-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,17]],"date-time":"2021-10-17T02:12:01Z","timestamp":1634436721000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-020-03931-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,17]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["3931"],"URL":"https:\/\/doi.org\/10.1007\/s11010-020-03931-3","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"type":"print","value":"0300-8177"},{"type":"electronic","value":"1573-4919"}],"subject":[],"published":{"date-parts":[[2020,10,17]]},"assertion":[{"value":"17 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors claim that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}